Purchase Order 75N92E22P00269
Award Date 7/20/22
Potential Completion Date 8/28/23
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health National Human Genome Research Institute awarded a $21,600 firm fixed price purchase order to Rodolfo Matos. The objective of this acquisition is to obtain bilingual services to support NIH IRB Protocol 000912, which examines genetic and social network correlates of rheumatoid arthritis outcomes in Hispanic populations. The work will be conducted in Potomac, Maryland over a one year period from August 2023 through August 2024. No subcontractors or set aside...
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian federal agency, awarded a firm fixed-price purchase order contract to Genecopoeia, Inc., a minority-owned and Asian-Pacific American-owned for-profit manufacturer of goods. The contract, valued at $22,320.00, was awarded on June 26, 2024, and has an ultimate completion date of May 1, 2025. This contract does not have a set-aside designation.</p>
- <p>This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Inbiomedic Sac, a for-profit limited liability company based in Peru, for $22,771.64 in research services. The contract has a period of performance through November 15, 2025 and does not have a set-aside designation. No additional information about larger contract vehicles or subcontractors is provided.</p>
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $119,840.00 firm fixed price purchase order to Cofactor Genomics, Inc., a minority-owned, self-certified small disadvantaged business, for DNA methylation sequencing profiles. The contract has a completion date of August 29, 2023. Cofactor Genomics, Inc. will perform the work in St. Louis, Missouri. The contract award resulted from a solicitation posted on July 8, 2021,...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order contract to LI, Lina, a minority owned, self-certified small disadvantaged, woman-owned small business, for $400,100.00 to provide expertise in adeno-associated viral (AAV) gene therapy. The contract does not have a set-aside designation and is based on a pre-solicitation opportunity posted in November 2018 seeking highly specialized...
- The Department of Health and Human Services' National Institutes of Health awarded a $35,103.50 firm fixed-price purchase order to Arima Genomics, Inc. for services to be performed in Bethesda, Maryland between August 7, 2023 and September 29, 2023. The award was made through the Office of Logistics and Acquisition Operations and no set aside designation or associated contract vehicle was indicated. Arima Genomics, Inc. will serve as the prime contractor on this contract to provide unspecified...
- <p>The National Human Genome Research Institute awarded a purchase order to Daniel Bravo Translation Services for $2,811.18 on February 4, 2016, under a Total Small Business set-aside. The minority-owned, Hispanic American-owned sole proprietorship performed work in Bethesda, Maryland. The order was issued as a firm fixed price purchase order with an ultimate completion date of December 28, 2020. The awardee specializes in English-to-Spanish translation services for federal health agencies.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Novogene Corporation Inc. valued at $19,084.52 on August 28, 2020. Novogene is a minority-owned small business. The order funds whole genome sequencing services to identify pathogenic mutations in patients with systemic lupus erythematosus. Work is performed in Chula Vista, California, with an ultimate completion date of September 4, 2020.</p>
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $14,182 purchase order to Carahsoft Technology Corp. to provide telecommunications software and hardware operation, maintenance, and repair services. The single award firm fixed price contract will be performed in Bethesda, Maryland over a one year period concluding in July 2024. No subcontractors or set aside designations were identified. The National Human Genome...